Rivka Riven-Kreitman

Title: Rivka Riven-Kreitman: Innovator in Pharmaceutical Compositions

Introduction

Rivka Riven-Kreitman is a notable inventor based in Kfar Sava, Israel. She has made significant contributions to the field of pharmaceutical compositions, particularly in the treatment of autoimmune diseases. Her innovative work has led to the development of formulations that are crucial for improving patient outcomes.

Latest Patents

Riven-Kreitman holds a patent for "Oral, nasal and pulmonary dosage formulations of copolymer 1." This patent discloses pharmaceutical compositions that are useful for treating autoimmune diseases in mammals. The active ingredient in these formulations is a therapeutically effective amount of Copolymer 1, combined with microcrystalline cellulose. The patent also outlines the processes for manufacturing such compositions.

Career Highlights

Rivka Riven-Kreitman is associated with Yeda Research and Development Company Ltd. Her work at this esteemed organization has allowed her to focus on innovative research and development in the pharmaceutical sector. She has successfully translated her research into practical applications that benefit patients.

Collaborations

Some of her notable coworkers include Adrian Gilbert and Milka Linenberg. Their collaborative efforts have contributed to the advancement of research in pharmaceutical formulations.

Conclusion

Rivka Riven-Kreitman is a pioneering inventor whose work in pharmaceutical compositions has the potential to transform treatment options for autoimmune diseases. Her contributions to the field are invaluable and highlight the importance of innovation in healthcare.